Back to company

Boehringer Ingelheim Animal Health Denmark A/S: Financial statements 2019

CVR: 13526990

Boehringer Ingelheim Animal Health Denmark A/S (CVR 13526990) has filed annual accounts for 2019. In 2019, the company reported revenue of DKK 596,526,000 and a net result of DKK -21,145,000 compared with DKK 7,631,000 the year before. That is an increase of 4% compared with the year before. The profit margin was -3.5%. Equity amounted to DKK 46,701,000. The solvency ratio was 13.6%. The company had 112 employees in the financial year.

Revenue
596,526,000 kr.
Gross Profit
100,394,000 kr.
Profit/Loss
-21,145,000 kr.
Equity
46,701,000 kr.
Total Assets
343,933,000 kr.
Employees
112

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2019596.5 mio.100.4 mio.-21.1 mio.46.7 mio.112
2018573.7 mio.109.7 mio.7.6 mio.70.5 mio.114
2017615 mio.923 mio.628.8 mio.687.5 mio.31
2016-39 mio.3.9 mio.27.6 mio.31
2015--3.7 mio.23.7 mio.35

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2019

Thomas Heinrich joins the board of Boehringer Ingelheim Animal Health Denmark A/SOct 28, 2019

As of October 28, 2019, Thomas Heinrich has joined the board of directors of Boehringer Ingelheim Animal Health Denmark A/S.

Matthias Hasenauer leaves the board of Boehringer Ingelheim Animal Health Denmark A/SOct 28, 2019

As of October 28, 2019, Matthias Hasenauer has left the board of directors of Boehringer Ingelheim Animal Health Denmark A/S.

Boehringer Ingelheim Animal Health Denmark A/S: The 2018 annual report is outJun 5, 2019

Boehringer Ingelheim Animal Health Denmark A/S has published its annual report for 2018. Revenue came to DKK 573,663,000, and the net result was DKK 7,631,000.

Nicolas Charles Dumoulin joins the board of Boehringer Ingelheim Animal Health Denmark A/SFeb 26, 2019

As of February 26, 2019, Nicolas Charles Dumoulin has joined the board of directors of Boehringer Ingelheim Animal Health Denmark A/S.

Nedim Pipic leaves the board of Boehringer Ingelheim Animal Health Denmark A/SFeb 25, 2019

As of February 25, 2019, Nedim Pipic has left the board of directors of Boehringer Ingelheim Animal Health Denmark A/S.

About Boehringer Ingelheim Animal Health Denmark A/S

Boehringer Ingelheim Animal Health Denmark A/S is a Danish company of the type Aktieselskab based in København S, founded in 1989. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named MERIAL NORDEN A/S and RHONE MERIEUX NORDEN A/S. The management consists of Dirk Neven Rauleder. The company is owned by Boehringer Ingelheim Animal Health International GmbH. The company has 95 employees. In 2025, the company reported revenue of DKK 725,936,000 and a net result of DKK -3,950,000 compared with DKK 40,407,000 the year before. Equity amounted to DKK 90,111,000.